Informationen:
Fehler:
ID
25670
Beschreibung
Naturlose (D-Tagatose) Efficacy Evaluation Trial; ODM derived from: https://clinicaltrials.gov/show/NCT00955747
Link
https://clinicaltrials.gov/show/NCT00955747
Stichworte
Versionen (1)
- 09.09.17 09.09.17 -
Hochgeladen am
9. September 2017
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Eligibility Type 2 Diabetes NCT00955747
Eligibility Type 2 Diabetes NCT00955747
- StudyEvent: Eligibility
Ähnliche Modelle
Eligibility Type 2 Diabetes NCT00955747
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Non-Insulin-Dependent Diabetes Mellitus WHO classification
Item
type 2 diabetics in accordance with who.
boolean
C0011860 (UMLS CUI [1,1])
C4267671 (UMLS CUI [1,2])
C4267671 (UMLS CUI [1,2])
Age
Item
male and female patients, between 18 and 75 years of age.
boolean
C0001779 (UMLS CUI [1])
Patient Diabetic | Pharmaceutical Preparations Absent | Diet therapy | Exercise regime
Item
diabetic patients who are not on medication for the disease. patients may be treated with diet and exercise.
boolean
C0030705 (UMLS CUI [1,1])
C0241863 (UMLS CUI [1,2])
C0013227 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
C0012159 (UMLS CUI [3])
C0454291 (UMLS CUI [4])
C0241863 (UMLS CUI [1,2])
C0013227 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
C0012159 (UMLS CUI [3])
C0454291 (UMLS CUI [4])
Creatinine clearance Normal | Liver function tests normal
Item
normal blood creatine clearance and normal liver function test results.
boolean
C0812399 (UMLS CUI [1,1])
C0205307 (UMLS CUI [1,2])
C0438235 (UMLS CUI [2])
C0205307 (UMLS CUI [1,2])
C0438235 (UMLS CUI [2])
Body mass index
Item
bmi less than or equal to 45kg/m2.
boolean
C1305855 (UMLS CUI [1])
Sulfonylurea | Glyburide | Glipizide | glimepiride | Chlorpropamide | Tolazamide | Acetohexamide | Tolbutamide | Thiazolidinediones | Metformin | Acarbose | Byetta | Insulin | Antidiabetics
Item
treatment with sulfonylurea (e.g., glyburide, glipizide, glimepiride, chlorpropamide, tolazamide, acetohexamide, or tolbutamide), tzds, metformin, acarbose, byetta, insulin, and any antidiabetic medications within the prior 3 months.
boolean
C0038766 (UMLS CUI [1])
C0017628 (UMLS CUI [2])
C0017642 (UMLS CUI [3])
C0061323 (UMLS CUI [4])
C0008287 (UMLS CUI [5])
C0040372 (UMLS CUI [6])
C0000992 (UMLS CUI [7])
C0040374 (UMLS CUI [8])
C1257987 (UMLS CUI [9])
C0025598 (UMLS CUI [10])
C0050393 (UMLS CUI [11])
C1636686 (UMLS CUI [12])
C0021641 (UMLS CUI [13])
C0935929 (UMLS CUI [14])
C0017628 (UMLS CUI [2])
C0017642 (UMLS CUI [3])
C0061323 (UMLS CUI [4])
C0008287 (UMLS CUI [5])
C0040372 (UMLS CUI [6])
C0000992 (UMLS CUI [7])
C0040374 (UMLS CUI [8])
C1257987 (UMLS CUI [9])
C0025598 (UMLS CUI [10])
C0050393 (UMLS CUI [11])
C1636686 (UMLS CUI [12])
C0021641 (UMLS CUI [13])
C0935929 (UMLS CUI [14])
Adrenergic beta-Antagonists | Thiazide Diuretics
Item
therapy with beta-blockers or thiazide diuretics within the prior 3 months.
boolean
C0001645 (UMLS CUI [1])
C0012802 (UMLS CUI [2])
C0012802 (UMLS CUI [2])
Pregnancy | Breast Feeding | Pregnancy, Planned | Contraceptive methods Inadequate
Item
pregnancy, breastfeeding, or intention of becoming pregnant or judged to be using inadequate contraceptive measure.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0032992 (UMLS CUI [3])
C0700589 (UMLS CUI [4,1])
C0205412 (UMLS CUI [4,2])
C0006147 (UMLS CUI [2])
C0032992 (UMLS CUI [3])
C0700589 (UMLS CUI [4,1])
C0205412 (UMLS CUI [4,2])
Gastrointestinal Diseases | Pharmaceutical Preparations Changing Intestinal Motility | Pharmaceutical Preparations Changing Intestinal Absorption
Item
documented gastrointestinal disease, or taking of medications likely to alter gut motility or absorption.
boolean
C0017178 (UMLS CUI [1])
C0013227 (UMLS CUI [2,1])
C0392747 (UMLS CUI [2,2])
C0021838 (UMLS CUI [2,3])
C0013227 (UMLS CUI [3,1])
C0392747 (UMLS CUI [3,2])
C0021826 (UMLS CUI [3,3])
C0013227 (UMLS CUI [2,1])
C0392747 (UMLS CUI [2,2])
C0021838 (UMLS CUI [2,3])
C0013227 (UMLS CUI [3,1])
C0392747 (UMLS CUI [3,2])
C0021826 (UMLS CUI [3,3])
Investigational New Drugs
Item
receiving any investigational drug within 30 days of the baseline visit.
boolean
C0013230 (UMLS CUI [1])